Literature DB >> 6161168

Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation.

E L Reinherz, C Morimoto, A C Penta, S F Schlossman.   

Abstract

Prior studies demonstrated that Ia molecules were expressed on a fraction of human peripheral T4+ inducer cells upon stimulation by soluble antigen. In the present study, we utilized a fluorescence-activated cell sorter to separate antigen-activated T4+,Ia+ and T4+,Ia- populations and characterized their function. It was found that the T4+,Ia+ population contained the majority of proliferating T cells as assessed by tritiated thymidine incorporation. This proliferation largely appeared to be nonspecific. Despite macrophage repletion, elimination of the Ia+ subset of T cells with monoclonal anti-Ia antibody and complement treatment equally diminished subsequent proliferation to both the triggering antigen and an unrelated antigen. Moreover, the antigen-induced Ia+ subset of T cells alone produced a nonspecific helper factor, LMF. In contrast, the the T4+,Ia- population showed minimal proliferation to soluble antigen and did not generate LMF. Nevertheless, both T4+,Ia+ and T4+,Ia- inducer T cells were required to generate maximal immunoglobulin production by B cells in an antigen-driven system. We conclude that the human T4+ inducer T cell subset is comprised of at least 2 functionally distinct subpopulations, which are capable of acting in a synergistic fashion to provide help to B cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161168

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

2.  Effect of recombinant soluble CD4 on human peripheral blood lymphocyte responses in vitro.

Authors:  M A Liu; T Liu
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

3.  Suppressor-cell dysfunction in children with histiocytosis-X.

Authors:  B T Shannon; W A Newton
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

4.  Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes.

Authors:  B L Davidson; J Faust; S Pessano; R P Daniele; G Rovera
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.

Authors:  H E Broxmeyer; L Juliano; L Lu; E Platzer; B Dupont
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  T cell surface antigen expression on lymphocytes of patients with AIDS during in vitro mitogen stimulation.

Authors:  C G Munn; J M Reuben; E M Hersh; P W Mansell; G R Newell
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 8.  Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures.

Authors:  P L Romain; S F Schlossman
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes.

Authors:  M K Brenner; A J Munro
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

10.  Correlation of morphological patterns of nucleoli in alveolar macrophages with HLA-DR antigen expression in sarcoidosis.

Authors:  W Popp; F J Wachtler
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.